-
Uncategorized2 months ago
Novartis’ radioligand therapy Lutathera could soon face generic competition
Novartis' radioligand therapy Lutathera could soon face generic competition
-
Uncategorized2 months ago
FDA approval of Regeneron’s hearing loss gene therapy breaks barriers
Approved Thursday via the FDA’s Commissioner’s National Priority Voucher program, Otarmeni is the first gene therapy for hearing loss—and the first treatment to target an underlying...
-
Uncategorized2 months agoRegenerative Medicine: Promise, Hype, and What Actually Works
From stem cells to platelet-rich plasma, regenerative medicine is often positioned as the future of healthcare. But not all approaches deliver on that promise. As interest...
-
Uncategorized2 months agoDrugmaker AbbVie chooses North Carolina for $1.4B manufacturing campus
The 185-acre site will be the company’s largest single investment to date, with a focus on small-volume parenteral products like vials and prefilled syringes. Read More
-
Uncategorized2 months ago
AACR 2026 Video Update: Cancer Research Edges Toward an AI-Driven Era
SAN DIEGO – At the American Association for Cancer Research (AACR) Annual Meeting 2026, the conversation around AI-driven cancer research has moved decisively past theory. Now...
-
Uncategorized2 months ago
Amneal inks $1.1B Kashiv buyout to pursue biosimilar market leadership
The takeover will give Amneal control of four facilities to manufacture biosimilars for a planned wave of launches in the coming years.
-
Uncategorized2 months agoOpinion: Dropping the flu vaccine requirement puts U.S. military readiness at risk
On Tuesday, Secretary of Defense Pete Hegseth announced that the men and women who defend our nation will be able to choose whether to be protected...
-
Uncategorized2 months agoSTAT+: CMS, FDA team up to fast-track reimbursement for breakthrough devices
Federal regulators on Thursday announced a new Medicare coverage pathway for devices deemed breakthroughs by the Food and Drug Administration. The program aims to address longstanding...
-
Uncategorized2 months ago
David Reese to retire from Amgen
David Reese to retire from Amgen
-
Uncategorized2 months ago
Regeneron ushers in new genetic medicine era with groundbreaking gene therapy approval
Travis Smith was a very serious baby. Born completely unable to hear, his mother Sierra struggled to see his personality shine through his mute world.
Hantavirus One-Shot mRNA Vaccine Fully Protects in Syrian Hamster Model
SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines
